Literature DB >> 26503753

Letter by Al-Kindi and Oliveira regarding article "cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study".

Sadeer G Al-Kindi1, Guilherme H Oliveira1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26503753     DOI: 10.1161/CIRCULATIONAHA.115.016258

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

1.  Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT).

Authors:  David Birnie; Rob S B Beanlands; Pablo Nery; Shawn D Aaron; Daniel A Culver; Robert A DeKemp; Lorne Gula; Andrew Ha; Jeffery S Healey; Yuko Inoue; Mark A Judson; Daniel Juneau; Kengo Kusano; Russell Quinn; Lena Rivard; Mustafa Toma; Amanda Varnava; George Wells; Melissa Wickremasinghe; Jordana Kron
Journal:  Am Heart J       Date:  2019-10-20       Impact factor: 4.749

2.  Sensitivity and specificity of chest imaging for sarcoidosis screening in patients with cardiac presentations.

Authors:  Juan J Russo; Pablo B Nery; Andrew C Ha; Jeff S Healey; Daniel Juneau; Lena Rivard; Matthias G Friedrich; Lorne Gula; Gerald Wisenberg; Robert deKemp; Santabhanu Chakrabarti; Tomasz W Hruczkowski; Russell Quinn; F Daniel Ramirez; Girish Dwivedi; Rob S B Beanlands; David H Birnie
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 3.  Epidemiology, Pathogenesis, and Diagnosis of Cardiac Sarcoidosis.

Authors:  Sheetal V Mathai; Snehal Patel; Ulrich P Jorde; Yogita Rochlani
Journal:  Methodist Debakey Cardiovasc J       Date:  2022-03-14

4.  Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review.

Authors:  Siavosh Fazelpour; Mouhannad M Sadek; Pablo B Nery; Rob S Beanlands; Niko Tzemos; Mustafa Toma; David H Birnie
Journal:  J Am Heart Assoc       Date:  2021-09-02       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.